Paper Details

  1. Home
  2. Paper Details

[Management of the bleeding risk associated with antiplatelet agents].

Author: GodierA, Houssany-PissotS, MartinA-C, TaylorG, ZlotnikD

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This paper reviewed the bleeding risk associated with antiplatelet agents, particularly the newer agents prasugrel and ticagrelor, which have increased the risk of major bleeding. It discusses the importance of platelet function monitoring and the optimal management of bleeding complications, including the challenging issue of reversing antiplatelet therapy, especially for ticagrelor.
Paper Details　
Original Abstract of the Article :
Like all antithrombotic drugs, antiplatelet agents expose to a risk of bleeding complications. Clinical research has extensively focused on the efficacy of these drugs to reduce ischemic events. The bleeding risk associated with them was solely considered as an inevitable and acceptable complication...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.revmed.2017.01.013

データ提供：米国国立医学図書館（NLM）

Antiplatelet Agents: Balancing the Benefits and Risks of Bleeding

[Antiplatelet agents] are essential medications for preventing blood clots, but they can also increase the risk of bleeding. This paper examines the challenges of managing this bleeding risk, particularly with the introduction of newer, more potent agents. The researchers navigate the complexities of antiplatelet therapy, like a skilled desert traveler navigating a treacherous sandstorm.

Managing the Bleeding Risk: A Balancing Act

Antiplatelet agents, like a double-edged sword in the desert, can offer protection from blood clots but also carry the risk of bleeding. This paper discusses the need for careful assessment of the bleeding risk, especially with newer agents that can increase the potential for bleeding. It's a delicate balancing act, like navigating a narrow path through a desert canyon.

A Call for Vigilance: Managing Antiplatelet Therapy

This paper, like a beacon in the desert, highlights the importance of vigilance in managing antiplatelet therapy. It emphasizes the need for careful patient monitoring, effective bleeding management strategies, and the development of strategies for reversing the effects of these medications.

Dr.Camel's Conclusion

This paper is like a desert expedition, exploring the complexities of antiplatelet therapy and the challenges of managing the risk of bleeding. The findings emphasize the importance of careful assessment, effective management, and ongoing research to optimize the use of these valuable medications.

Date :
  1. Date Completed 2017-10-31
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28528236

DOI: Digital Object Identifier

10.1016/j.revmed.2017.01.013

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.